Evidence of Atlantic salmon Salmo salar fry movement between fresh water and a brackish environment

This study reports descent of Atlantic salmon Salmo salar fry from their natal streams to brackish waters of the Baltic Sea and their use of this environment as an alternative rearing habitat before ascending back to freshwater streams. To the authors' knowledge, residency in a brackish environment has not previously been demonstrated in S. salar fry. Recruitment success and evolutionary significance of this alternative life-history strategy are presently not known.

Time-dependent effects of post-trial amphetamine treatment in rats: evidence for enhanced storage of representational memory

Two studies were conducted to test the ability of post-trial amphetamine treatment to improve later recall in a nonaversively motivated task. These studies utilized 8- and 12-arm radial mazes, respectively, with an 11-h retention interval imposed after the rat traversed half the arms of the maze (termed, the to-be-remembered-event, or TBRE). In Experiment 1, the rats were injected with amphetamine (0, .25, and .50 mg/kg) immediately after the TBRE. Because the drug treatment improved retention, a time dependency study was conducted in which the drug (0 and .33 mg/kg) was administered 0, 3, and 6 h after the TBRE. The finding that amphetamine injection at 0, but not 3, h post-trial improved later recall indicates that the benefit derived from the former treatment is not due to proactive influences at the time of the retention test. Drug treatment 6 h post-trial produced a borderline improvement of recall; possible mechanisms are discussed. Two conclusions can be drawn from these results: (1) amphetamine administration can improve recall under conditions in which this effect cannot be attributed to alterations in information processing during either the learning or the retention sessions, indicating that the drug modulates memory storage processes; and (2) amphetamine treatment can improve working memory, thus excluding an alternative interpretation for the previous reports of impaired short-term memory in animals, all of which entailed assessments of working memory. The possibility remains, however, that the impairment seen in these tasks reflects the requirement for erasure of information from previous trials within each daily session, rather than the duration of the retention interval.

A vasopressin metabolite increases attentional selectivity

Two behavioral paradigms were used to assess the effect of a vasopressin metabolite, AVP4-9, on selectivity of attention. The effects observed in a multiple-cue task indicated that AVP4-9 treatment increased the extent to which attention was controlled by the dominant cues in the environment. When these stimuli predicted reward, the peptide treatment facilitated learning, but when these cues were nonpredictive, the treatment hindered learning. In a redundant learning paradigm, administration of the lower dose of AVP4-9 (1 microgram/kg) prevented animals from learning about an added, equally predictive (i.e., redundant) set of cues, suggesting that this treatment caused selective attending to the originally presented stimuli, whose relationship with reward had already been learned. The results of these two studies provide converging evidence that AVP4-9 treatment increases the selectivity of attention, with preferential processing of dominant information. Parallels with the putative attentional effects of increased arousal are discussed.

Cognitive profile of rats exposed to lactational hyperphenylalaninemia: correspondence with human mental retardation

The present study was designed to provide further information on the enduring cognitive effects of experimental phenylketonuria (PKU) in rats, produced by the administration of alpha-methylphenylalanine and phenylalanine on postnatal days 3-21. These rats evidenced: (1) impaired learning set formation, (2) stimulus perseveration, particularly after an error, and (3) difficulty in utilizing the less salient features of their environment in mastering discrimination problems. In contrast, long-term memory function and the ability to form simple associations did not differ from controls. This pattern of intact and impaired cognitive functions bears remarkable similarity to that of mentally retarded humans and neonatally hyperphenylalaninemic rhesus monkeys, thus affirming the use of rats to study mental retardation. In addition, possible reasons for the mildness of the impairments commonly observed in animal models of severe mental retardation syndromes are discussed. We suggest that transfer of learning paradigms that assess the animal's ability to use information acquired in other problems are more likely to uncover significant cognitive impairments in such models than are procedures that test only the animals' ability to solve a single problem.

Enhancement and impairment of memory retrieval by a vasopressin metabolite: an interaction with the accessibility of the memory

A series of 3 experiments was conducted to determine the generalizability of the improved recall seen with pretest administration of vasopressin in aversively motivated tasks. The learning paradigm selected for this purpose assessed the transmission of a food preference between rats; retention intervals of 8, 10, and 14 days were used in the 3 experiments, respectively. Pretest subcutaneous injection of a vasopressin metabolite, AVP4-9, significantly improved recall under conditions in which memory was poor in vehicle-treated rats but significantly impaired memory at a time when good recall was evident in controls. These findings support the postulate that administration of vasopressin or its metabolites modulate memory retrieval processes and suggest that the nature of this effect depends on the degree of forgetting that has occurred.

Enhancement and impairment of memory retrieval by a vasopressin metabolite: An interaction with the accessibility of the memory

A series of 3 experiments was conducted to determine the generalizability of the improved recall seen with pretest administration of vasopressin in aversively motivated tasks. The learning paradigm selected for this purpose assessed the transmission of a food preference between rats; retention intervals of 8, 10, and 14 days were used in the 3 experiments, respectively. Pretest subcutaneous injection of a vasopressin metabolite, AVP4-9, significantly improved recall under conditions in which memory was poor in vehicle-treated rats but significantly impaired memory at a time when good recall was evident in controls. These findings support the postulate that administration of vasopressin or its metabolites modulate memory retrieval processes and suggest that the nature of this effect depends on the degree of forgetting that has occurred.